Back to trial details

Intake questionnaire

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

Applying to University of Chicago Comprehensive Cancer Center at Silver Cross · New Lenox, Illinois

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with HER2-positive Metastatic Breast Cancer?
3. Are you able to travel to New Lenox for study visits?